Anaptysbio ANAB Cash Flow Statement (2016-2026)

NASDAQ ANAB
$45.43 -3.81 (-7.74%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Anaptysbio Quarterly Cash Flow Statement

Periods 41 quarters
Latest Mar 2026

Anaptysbio reported cash from operations of -$25.92M and free cash flow of -$25.94M for the quarter ended Mar 2026, down 142.2% year over year. This cash flow statement covers 41 quarters of results from Mar 2016 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income
-0.43M-6.67M-32.54M-36.26M-32.55M-33.50M-26.41M-44.26M-39.85M-37.31M-42.21M-43.94M-46.66M-32.85M-21.78M-39.33M-38.63M15.11M49.61M-52.88M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.16M0.17M0.17M0.16M0.16M0.17M0.18M0.17M0.16M0.16M0.17M0.16M0.15M0.14M0.15M0.15M0.14M0.14M0.13M0.13M
Share-based CompensationStock Comp.
3.69M4.36M3.98M7.74M6.66M6.27M6.69M8.86M8.43M7.81M8.11M10.13M7.54M8.19M8.18M9.17M9.24M9.16M8.51M14.22M
Deferred Taxes
3.54M
Gains from Investment SecuritiesGains Investment
-0.13M-0.10M-0.10M-0.16M0.16M0.78M1.72M2.19M2.18M2.99M3.15M2.97M2.48M2.57M2.30M1.67M1.60M1.13M0.34M0.01M
Other non-cash itemsOther Non-Cash
0.63M0.50M1.67M0.41M0.41M0.42M0.42M4.76M4.78M4.87M-12.69M6.76M11.39M15.87M-32.23M0.46M38.13M22.99M-59.71M0.48M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in Accured ExpensesChange Accured Exp.
5.75M-0.19M-5.32M3.54M0.08M1.26M4.83M8.53M6.61M-2.70M-1.50M-5.17M8.02M3.36M-40.05M-24.03M-22.32M-18.56M-22.41M-17.82M
Change in TaxesChange Taxes
Change in Other Operating AssetsOther Assets Change
0.23M5.43M-6.63M1.27M4.23M-2.67M-1.47M0.05M2.95M5.88M0.74M1.80M-1.15M1.78M28.27M-23.41M3.12M54.57M-42.81M-9.60M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.11M0.16M0.02M-0.36M-0.37M-0.38M-0.39M-0.39M-0.41M-0.42M-0.42M-0.43M-0.44M-0.45M-0.46M-0.46M-0.48M-0.49M-0.49M-0.50M
Other Working Capital ChangesOther WC Changes
-0.33M-5.27M6.65M-1.63M-4.60M2.29M1.08M-0.44M-3.36M-6.30M-1.16M-2.23M0.71M-2.24M-28.73M22.95M-3.60M-55.06M42.31M9.11M
Cash from OperationsCash from Ops.
9.59M-7.01M-25.30M-21.01M-24.15M-17.75M-10.69M-24.57M-25.41M-36.47M-34.35M-37.25M-21.32M-10.09M-66.67M-10.70M-40.24M-27.36M98.00M-25.92M
Investing Activities
Capital ExpendituresCapex
0.86M0.17M0.01M0.06M0.08M0.05M0.18M0.18M0.19M0.16M0.28M0.03M0.03M0.04M0.26M0.04M0.04M0.01M0.00M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.86M-0.17M-0.01M-0.06M-0.08M-0.05M-0.18M-0.18M-0.19M-0.16M-0.28M-0.03M-0.03M-0.04M-0.26M-0.04M-0.04M-0.01M0.00M-0.02M
Purchase of InvestmentsInvestments Purchased
3.50M16.75M92.18M322.48M172.32M180.13M127.58M48.56M119.01M70.05M66.31M59.00M149.15M51.35M120.88M122.55M54.21M19.66M
Sale and Maturity of InvestmentsInvestments Sold
42.32M27.74M25.50M9.62M101.40M147.75M149.25M134.13M98.74M100.85M115.77M127.64M146.74M110.00M91.75M137.43M90.65M122.95M73.50M35.00M
Cash from Investing ActivitiesCash from Investing
37.96M10.84M-66.69M-312.91M-71.00M-32.43M21.50M85.40M-20.46M30.64M49.18M68.62M-2.44M58.62M-29.40M14.85M36.40M103.28M73.50M34.98M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
0.55M0.24M1.59M4.84M0.87M2.70M3.42M1.27M0.78M0.16M0.26M0.81M0.98M98.50M0.56M0.29M1.42M0.34M12.21M14.02M
Shares Repurchased
37.53M12.47M0.46M4.42M51.10M9.72M3.38M
Net Shares Issued and RepurchasedNet Shares Issued
0.55M0.24M1.59M4.84M0.87M2.70M3.42M-36.26M-11.69M0.16M0.26M0.81M0.98M98.50M0.10M-4.13M-49.68M-9.38M8.83M14.02M
Net Equity Issued and RepurchasedNet Equity Issued
0.55M0.24M1.59M4.84M0.87M2.70M3.42M-36.26M-11.69M0.16M0.26M0.81M0.98M98.50M0.10M-4.13M-49.68M-9.38M8.83M14.02M
Other financing activitiesOther financing
-0.24M-0.43M-0.67M1.34M-0.04M0.04M-7.50M-0.04M-0.44M-7.52M-1.45M
Cash from Financing ActivitiesCash from Financing
0.55M0.24M251.34M4.61M0.43M37.03M1.95M-37.57M-13.49M-3.07M-5.16M-13.63M41.89M71.23M27.57M-28.59M-50.50M-10.39M-43.13M1.21M
Additional items
Change in Cash
48.11M4.07M159.34M-329.32M-94.71M-13.15M12.76M23.25M-59.36M-8.91M9.67M17.73M18.13M119.76M-68.50M-24.44M-54.34M65.54M128.36M10.27M
Ending Cash Balance
332.31M336.39M495.73M166.41M71.70M58.55M71.31M94.56M35.21M26.30M35.97M53.70M71.82M191.58M123.08M98.64M44.30M109.83M238.20M248.47M
Free Cash FlowFCF
8.73M-7.18M-25.32M-21.07M-24.23M-17.80M-10.86M-24.74M-25.60M-36.64M-34.63M-37.28M-21.36M-10.13M-66.94M-10.74M-40.28M-27.37M98.00M-25.94M
Net Cash FlowNCF
48.11M4.07M159.34M-329.32M-94.71M-13.15M12.76M23.25M-59.36M-8.91M9.67M17.73M18.13M119.76M-68.50M-24.44M-54.34M65.54M128.36M10.27M
Interest Paid
42.13M18.10M17.80M21.03M23.07M20.83M
Income Taxes PaidTaxes Paid
0.01M0.04M

Anaptysbio Cash Flow Statement API

Pull Anaptysbio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ANAB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY